We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$29.2B
AUM Growth
+$1.4B
(+5%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
23.08%
Holding
3,780
New
179
Increased
1,287
Reduced
1,288
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$43M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$29.1M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$28.4M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$27.3M |
| 5 |
Amazon
AMZN
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$44.4M |
| 2 |
US Bancorp
USB
|
+$24.3M |
| 3 |
STJ
St Jude Medical
STJ
|
+$23.2M |
| 4 |
SE
Spectra Energy Corp Wi
SE
|
+$20.8M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.17% |
| 2 | Financials | 11.31% |
| 3 | Healthcare | 10.5% |
| 4 | Technology | 9.1% |
| 5 | Consumer Staples | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Texas Roadhouse
TXRH
$12.6B
| $3.89M | 0.01% |
87,366
+2,313
| +3% | +$104K |
|
552
Lumen
LUMN
$6.57B
| $3.89M | 0.01% |
164,961
-4,589
| -3% | -$112K |
|
553
Agilent Technologies
A
$39.2B
| $3.84M | 0.01% |
72,633
-1,732
| -2% | -$87.4K |
|
554
CoStar Group
CSGP
$11.4B
| $3.83M | 0.01% |
185,110
-3,630
| -2% | -$73.8K |
|
|
CHL
555
DELISTED
China Mobile Limited
CHL
| $3.83M | 0.01% |
69,412
+8,575
| +14% | +$479K |
|
556
Tyson Foods
TSN
$20.2B
| $3.82M | 0.01% |
61,965
-14,234
| -19% | -$897K |
|
|
CA
557
DELISTED
CA, Inc.
CA
| $3.8M | 0.01% |
119,813
-22,151
| -16% | -$713K |
|
558
MarketAxess Holdings
MKTX
$4.1B
| $3.78M | 0.01% |
20,132
-228
| -1% | -$41.3K |
|
559
Progressive
PGR
$124B
| $3.77M | 0.01% |
96,306
-5,077
| -5% | -$194K |
|
560
ICICI Bank
IBN
$106B
| $3.77M | 0.01% |
481,664
+145,040
| +43% | +$1.08M |
|
561
Monolithic Power Systems
MPWR
$65.3B
| $3.75M | 0.01% |
40,738
+3,336
| +9% | +$296K |
|
562
iShares Core MSCI Pacific ETF
IPAC
$2.6B
| $3.74M | 0.01% |
71,121
+49,352
| +227% | +$2.55M |
|
|
ULTI
563
DELISTED
Ultimate Software Group Inc
ULTI
| $3.73M | 0.01% |
19,135
-414
| -2% | -$80.6K |
|
564
Applied Industrial Technologies
AIT
$12.8B
| $3.71M | 0.01% |
60,044
-8,700
| -13% | -$537K |
|
565
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $3.71M | 0.01% |
77,728
+276
| +0.4% | +$13K |
|
566
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $3.67M | 0.01% |
34,788
+1,980
| +6% | +$208K |
|
567
National Grid
NGG
$82B
| $3.61M | 0.01% |
58,957
-107,539
| -65% | -$6.21M |
|
568
Ventas
VTR
$48.7B
| $3.61M | 0.01% |
55,477
+1,319
| +2% | +$82.1K |
|
569
Brown-Forman Class B
BF.B
$11.9B
| $3.58M | 0.01% |
121,219
+2,928
| +2% | +$87.1K |
|
570
NetApp
NTAP
$32.7B
| $3.57M | 0.01% |
85,401
+66,305
| +347% | +$2.61M |
|
571
Fortune Brands Innovations
FBIN
$6.08B
| $3.56M | 0.01% |
68,550
-6,023
| -8% | -$295K |
|
|
VISN
572
Vistance Networks Inc
VISN
$2.66B
| $3.55M | 0.01% |
85,120
+11,291
| +15% | +$435K |
|
573
Dollar General
DG
$26B
| $3.54M | 0.01% |
50,818
-336
| -0.7% | -$24.6K |
|
574
Hubbell
HUBB
$25.5B
| $3.54M | 0.01% |
29,477
-428
| -1% | -$51.4K |
|
575
Teva Pharmaceuticals
TEVA
$35.9B
| $3.54M | 0.01% |
110,226
-17,420
| -14% | -$594K |
|
Similar funds
US Bancorp's Q1 2017 Portfolio in Review
As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
- US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
- US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
- US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
- US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
- US Bancorp opened 179 new positions and closed 176 in Q1 2017.
- US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.
Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.